Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06553313

Analysis of Protein Expression in Serum of KOA Subjects

Analysis of Protein Expression in Serum of Subjects With Knee Arthritis Control Group and Evaluation by Meridian and Pulse Wave Energy

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
50 (estimated)
Sponsor
China Medical University Hospital · Academic / Other
Sex
All
Age
50 Years
Healthy volunteers
Accepted

Summary

In the previous study "Using omics technology to explore the mechanism of acupuncture treatment of different acupoints of knee osteoarthritis: a randomized controlled trial (CMUH109-REC3-113)", we found that acupuncture for knee osteoarthritis(KOA) significantly reduces inflammation, apoptosis, and metabolism-related serum protein profiles. However, due to the lack of serum protein data from the control group, it is impossible to establish standard values for comparison. To analyze the protein expression in the serum of KOA control group subjects, we also measured the spectral energy values of the radial artery pulse wave obtained from the pulse sphygmograph and the meridian energy values obtained from Ryodoraku. The results obtained can be compared with previous studies, thus this experiment was designed.

Conditions

Interventions

TypeNameDescription
DEVICEMicro-Western ArrayThe subjects first took the energy measurement of the pulse sphygmograph and Ryodoraku, rested for 20 minutes, and then repeated the measurements again. In order to comply with the acupuncture treatment course was 5 weeks in the previous study, we have two blood draw point. Each subject's blood was drawn for the first time, and then for the second time in 5 weeks later. Each subject drew 10ml of blood each time. The blood samples are analyzed by Micro-Western Array (MWA) and Enzyme-linked immunosorbent assay (ELISA) to obtain the serum protein content value of healthy individuals.

Timeline

Start date
2024-08-04
Primary completion
2025-07-23
Completion
2025-07-23
First posted
2024-08-14
Last updated
2024-08-14

Locations

1 site across 1 country: Taiwan

Source: ClinicalTrials.gov record NCT06553313. Inclusion in this directory is not an endorsement.